- Home
- KNW vs PYPD Comparison
KNW vs PYPD Comparison
Compare KNW & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNW
- PYPD
- Stock Information
- Founded
- KNW 1998
- PYPD 2008
- Country
- KNW United States
- PYPD Israel
- Employees
- KNW N/A
- PYPD N/A
- Industry
- KNW Industrial Machinery/Components
- PYPD Medical/Dental Instruments
- Sector
- KNW Industrials
- PYPD Health Care
- Exchange
- KNW Nasdaq
- PYPD Nasdaq
- Market Cap
- KNW 25.6M
- PYPD 24.2M
- IPO Year
- KNW N/A
- PYPD 2020
- Fundamental
- Price
- KNW $0.25
- PYPD $3.55
- Analyst Decision
- KNW Buy
- PYPD Strong Buy
- Analyst Count
- KNW 1
- PYPD 2
- Target Price
- KNW $1.00
- PYPD $12.00
- AVG Volume (30 Days)
- KNW 184.3K
- PYPD 10.5K
- Earning Date
- KNW 11-15-2024
- PYPD 11-13-2024
- Dividend Yield
- KNW N/A
- PYPD N/A
- EPS Growth
- KNW N/A
- PYPD N/A
- EPS
- KNW N/A
- PYPD N/A
- Revenue
- KNW N/A
- PYPD N/A
- Revenue This Year
- KNW N/A
- PYPD N/A
- Revenue Next Year
- KNW N/A
- PYPD N/A
- P/E Ratio
- KNW N/A
- PYPD N/A
- Revenue Growth
- KNW N/A
- PYPD N/A
- 52 Week Low
- KNW $0.18
- PYPD $2.95
- 52 Week High
- KNW $0.94
- PYPD $9.20
- Technical
- Relative Strength Index (RSI)
- KNW 55.17
- PYPD 53.48
- Support Level
- KNW $0.20
- PYPD $3.23
- Resistance Level
- KNW $0.28
- PYPD $3.62
- Average True Range (ATR)
- KNW 0.02
- PYPD 0.20
- MACD
- KNW 0.00
- PYPD 0.01
- Stochastic Oscillator
- KNW 57.38
- PYPD 81.01
About KNW Know Labs Inc.
Know Labs Inc is a medical diagnostic. The company is focused on the development, marketing, and sales of proprietary technologies that are capable of uniquely identifying or authenticating almost any substance or material using electromagnetic energy to record, detect, and identify the signature of the substance or material known as Bio-RFID and ChromaID technologies. It is developing a wearable device that will measure blood glucose without fingersticks or microneedles.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.